Vanguard Group Inc Foghorn Therapeutics Inc. Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,884,673 shares of FHTX stock, worth $8.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,884,673
Previous 1,834,628 2.73%
Holding current value
$8.74 Million
Previous $6.7 Million 32.27%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
$3.15 - $4.9 $157,641 - $245,220
50,045 Added 2.73%
1,884,673 $8.86 Million
Q1 2025

May 09, 2025
BUY
$3.52 - $6.16 $299,087 - $523,402
84,968 Added 4.86%
1,834,628 $6.7 Million
Q4 2024

Feb 11, 2025
BUY
$4.61 - $9.35 $81,509 - $165,317
17,681 Added 1.02%
1,749,660 $8.26 Million
Q3 2024

Nov 13, 2024
BUY
$4.8 - $9.99 $3.23 Million - $6.72 Million
672,494 Added 63.47%
1,731,979 $16.1 Million
Q2 2024

Aug 13, 2024
SELL
$5.05 - $8.0 $217,190 - $344,064
-43,008 Reduced 3.9%
1,059,485 $6.09 Million
Q1 2024

May 10, 2024
BUY
$2.82 - $7.94 $218,211 - $614,397
77,380 Added 7.55%
1,102,493 $7.4 Million
Q4 2023

Feb 14, 2024
BUY
$2.94 - $6.76 $18,915 - $43,493
6,434 Added 0.63%
1,025,113 $6.61 Million
Q3 2023

Nov 14, 2023
BUY
$5.0 - $9.87 $18,710 - $36,933
3,742 Added 0.37%
1,018,679 $5.09 Million
Q2 2023

Aug 14, 2023
SELL
$5.37 - $8.84 $37,740 - $62,127
-7,028 Reduced 0.69%
1,014,937 $7.15 Million
Q1 2023

May 15, 2023
BUY
$4.66 - $8.99 $18,998 - $36,652
4,077 Added 0.4%
1,021,965 $6.34 Million
Q4 2022

Feb 10, 2023
BUY
$5.44 - $9.46 $27,015 - $46,978
4,966 Added 0.49%
1,017,888 $6.49 Million
Q3 2022

Nov 14, 2022
BUY
$7.52 - $18.01 $40,104 - $96,047
5,333 Added 0.53%
1,012,922 $8.69 Million
Q2 2022

Aug 12, 2022
BUY
$8.48 - $16.84 $1.25 Million - $2.47 Million
146,819 Added 17.06%
1,007,589 $13.7 Million
Q1 2022

May 13, 2022
BUY
$8.87 - $22.1 $142,620 - $355,345
16,079 Added 1.9%
860,770 $13.1 Million
Q4 2021

Feb 14, 2022
BUY
$10.79 - $22.87 $51,511 - $109,181
4,774 Added 0.57%
844,691 $19.3 Million
Q3 2021

Nov 12, 2021
BUY
$8.33 - $15.02 $1.3 Million - $2.35 Million
156,139 Added 22.83%
839,917 $11.7 Million
Q2 2021

Aug 13, 2021
BUY
$9.32 - $13.26 $6.37 Million - $9.07 Million
683,778 New
683,778 $7.3 Million

Others Institutions Holding FHTX

# of Institutions
83
Shares Held
37M
Call Options Held
100
Put Options Held
0
View Full List

About Foghorn Therapeutics Inc.

FHTX Quotes by TradingView
  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $193M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email